June IPOs cement first half record at 89

With newly public biotechs raising $633.3 million since Thursday’s market close, 23 biopharma companies have now raised $3.5 billion in IPOs so far in June.

Leading the companies listing Friday, Graphite Bio Inc. (NASDAQ:GRPH) raised $238 million in an upsized deal, selling 14 million shares at $17 million for a postmoney valuation of $955 million. The CRISPR-based gene editing company was one of three Versant Ventures portfolio companies to go public this month...